Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

SSSE:600557
12.14
CNY
0.00
(0.00%)
0.56EPS
22.04P/E
6.96BMarket Cap
Apr 05Next Earn
Jiangsu Kanion Pharmaceutical Co. Ltd. Class A
SSE:600557
(Shanghai Stock Exchange)

Recent

price

12.14

P/E

ratio

22.04

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.24
2.57
3.14
3.75
4.28
4.59
4.9
5.52
6.47
7.74
5.07
6.37
7.51
8.49
6.76
5.85
5.97
Revenue per Share
0.3
0.31
0.4
0.5
0.53
0.59
0.61
0.63
0.7
0.86
0.44
0.56
0.75
0.81
0.68
0.54
0.56
Basic EPS, GAAP
-0.2
-0.34
-0.07
0.08
- -
0.23
-0.04
0.21
0.57
0.74
0.85
1.29
1.35
1.15
0.39
0.16
- -
Free Cash Flow per Basic Share
0.09
0.09
0.11
0.14
0.17
0.14
0.1
0.15
0.14
0.14
0.11
0.02
- -
0.22
0.37
0.16
- -
Dividend per Share
2.02
2.36
2.69
3.14
4.05
4.56
5.1
5.65
6.31
6.64
7.03
7.26
8.13
8.45
7.76
8.51
8.8
Book Value per Share
1.73
2.06
2.32
2.67
3.58
3.95
4.38
4.88
5.44
5.79
6.12
6.43
7.35
7.71
7.04
7.69
7.93
Tangible Book Value per Share
605
597
605
594
599
614
613
593
592
590
598
572
579
573
576
563
565
Basic Weighted Avg Shares
1,358
1,538
1,903
2,230
2,563
2,820
3,000
3,275
3,825
4,566
3,032
3,649
4,351
4,864
3,898
3,293
3,373
Sales/Revenue/Turnover
14.99
14.75
15.83
16.34
16.86
15.84
14.36
14.99
13.89
13.42
12.19
9.65
10.16
9.2
9.9
11.39
10.97
Operating Margin (%)
36
46
47
63
89
107
139
150
163
166
160
187
190
195
200
191
- -
Depreciation Expense
181
183
240
297
320
362
374
374
414
507
263
321
434
464
392
304
316
Net Income, GAAP
9.98
11.38
12.52
13.24
13.26
12.78
12.42
13.83
12.2
10.23
6.93
1.19
0.85
0.88
1
13.82
12.55
Effective Tax Rate (%)
13.31
11.87
12.59
13.32
12.47
12.85
12.46
11.41
10.83
11.1
8.67
8.79
9.99
9.54
10.05
9.23
9.36
Profit Margin (%)
445
640
562
448
830
881
904
1,094
1,133
977
1,190
1,421
1,949
2,033
1,551
1,592
1,461
Working Capital
58
148
195
167
125
45
- -
2
2
2
- -
- -
- -
- -
- -
1
1
LT Debt
1,244
1,475
1,651
1,935
2,556
2,871
3,206
3,594
4,014
4,087
4,327
4,473
4,934
5,019
4,705
5,012
5,179
Total Equity
11.44
8.7
9.08
9.84
9.96
10.14
9.78
9.65
9.34
10.88
6.78
7.25
9.25
9.06
7.77
6.53
6.42
Return on Invested Capital (%)
13.72
11.31
12.4
12.81
12.07
11.79
11.98
10.66
9.98
11.26
5.71
6.88
8.9
9.73
8.74
6.44
6.54
Return on Capital (%)
15.85
13.8
15.73
17.02
14.6
13.65
12.55
11.28
11.23
12.96
6.49
7.57
9.59
9.58
8.29
6.51
6.55
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
566
566
566
Market Capitalization
7,717
6,664
6,964

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
3,206
3,193
3,088
Cash, Cash Equivalents & STI
2,036
1,957
2,039
Accounts Receivable, Net
488
517
418
Inventories
458
406
375
Total Current Liabilities
1,657
1,665
1,628
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.88%
3.14%
6.53%
Free Cash Flow
-55.26%
-18.3%
-60.67%
Net Income, GAAP
1.45%
5.25%
-22.44%
Sales/Revenue/Turnover
3.41%
3.2%
-15.52%
Total Cash Common Dividend
490.77%
982.69%
-56.97%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,358
901
850
788
3,898
2025
878
764
- -
950
3,293
2026
831
830
761
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.23
0.2
0.16
0.06
0.68
2025
0.15
0.1
- -
0.18
0.54
2026
0.14
0.12
0.11
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.37
- -
- -
0.37
2025
- -
- -
- -
- -
0.16
2026
- -
- -
- -
- -
- -
Business
I did not find specific data regarding recent changes, partnerships, funding, acquisitions, or product launches for Jiangsu Kanion Pharmaceutical Co., Ltd. (Ticker: 600557.SS) in the search results explicitly. To provide a comprehensive and updated description, I will now search for detailed company profile information and latest news related directly to Jiangsu Kanion Pharmaceutical Co., Ltd. and its ticker 600557.SS.